Henkel's Sales Slightly Beat Expectations
By Mauro Orru
Henkel posted sales slightly ahead of analysts' forecasts for last year.
The German chemical and consumer-goods company on Monday reported sales of 21.51 billion euros ($23.32 billion) for 2023, down 3.9% in reported terms but up 4.2% organically from the previous year.
The company's adjusted return on sales increased to 11.9% from 10.4% in 2022. Adjusted earnings per preferred share--a closely watched profitability metric--grew 20% at constant exchange rates to EUR4.35.
Henkel said it would propose a 2023 dividend of EUR1.85 per preferred share and EUR1.83 per ordinary share to its annual general meeting on April 22, the same it paid for the previous year.
The group was expected to post annual sales of EUR21.50 billion, an adjusted return on sales of 12% and adjusted earnings per preferred share of EUR4.35, according to a Vara Research consensus based on estimates from 18 analysts.
This year, the group is forecasting organic sales growth of 2% to 4%, an adjusted return on sales between 12% and 13.5% and adjusted earnings per preferred share up 5% to 20% at constant exchange rates.
Write to Mauro Orru at mauro.orru@wsj.com
(END) Dow Jones Newswires
March 04, 2024 02:01 ET (07:01 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom